Other studies have indicated that CCL2 expression accelerates amyloidosis in an amyloid precursor protein (APP)/CCL2 bigenic mouse model, suggesting a different role of CCL2 in resident microglia and ultimately the AD pathology of these mice [19]. This evidence concerns the gene CCL2 and amyloidosis.